Sniecinski Megan 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 18, 2019
Insider Transaction Report
Form 4
Sniecinski Megan
Chief Business Officer
Transactions
- Purchase
Common Stock
2019-11-18$1.45/sh+45,000$65,250→ 45,000 total
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 18, 2019
Common Stock